Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Check Also

How gaming and pop culture collided to redefine India’s youth entertainment in 2025

A year defined by high-profile events, major music festivals, blockbuster celebrity integrations, and the rise …